Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile
Rating (average): (0)
Business Name: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Profile
Business Sector:
Short Business Description: Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
Long Business Description:

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in clinical studies in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus erythematosus.

[stock_market_widget type=”chart” symbol=”CRBP” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]

 

Business Website Address: Click Here To Visit
Business Address: 500 River Ridge Drive
Second Floor
Norwood, MA United States
ZIP Code: 02062
Stock Symbol (if applicable): CRBP
Country: USA
State: Massachusetts

Ratings

There are no reviews yet.

Please login to rate this listing.